1-(3-Chloropyridin-4-yl)piperazine

Catalog No.: 
ACVDBO279
CAS No.: 
87394-66-9
Molecular Formula: 
C9H12ClN3
Molecular Weight: 
197.67
1-(3-Chloropyridin-4-yl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$148.00InquiryInquiry
100mg98%$214.00InquiryInquiry
250mg98%$297.00InquiryInquiry
1g98%$582.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-Chloropyridin-4-yl)piperazine
IUPAC Name1-(3-chloropyridin-4-yl)piperazine
MDL No.MFCD20663953
Molecular FormulaC9H12ClN3
Molecular Weight197.67
SMILESClC1=C(N2CCNCC2)C=CN=C1
InChI KeyWZZPTVIAALKWBS-UHFFFAOYSA-N
Synonym1-(3-chloropyridin-4-yl)piperazine;Piperazine, 1-(3-chloro-4-pyridinyl)-
CAS No.87394-66-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVDBO279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACNJZT105 route compound structure diagram
    ACNJZT105883107-69-5In Stock
  4. Then
  5. ACVDBO279 route product structure diagram
    ACVDBO27987394-66-9
Inquiry

2. ACVDBO279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACLQCN650 route compound structure diagram
    ACLQCN65055934-00-4In Stock
  4. Then
  5. ACVDBO279 route product structure diagram
    ACVDBO27987394-66-9
Inquiry

3. ACVDBO279 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVDBO279 route product structure diagram
    ACVDBO27987394-66-9
Inquiry

Comments (0)